Insurance Data Protection Act

**What Happened:** Representative Scott Fitzgerald (R-WI) introduced HR3437, the Insurance Data Protection Act, in the House on May 15, 2025. It was referred to the Committees on Financial Services and Agriculture. The bill eliminates the Federal Insurance Office's (FIO) subpoena authority under 31 U.S.C. 313(e) and the Office of Financial Research's (OFR) subpoena power over insurance companies under 12 U.S.C. 5343(f)(1). It also establishes a data collection hierarchy requiring financial regulators to seek data from state insurance regulators or public sources before directly collecting from insurers. An identical companion bill, S1544, was introduced in the Senate and referred to the Banking Committee, creating a bipartisan pathway. **The Money Trail:** This bill does NOT authorize or appropriate any federal spending — it is a regulatory relief measure, not a funding bill. The economic impact is cost reduction for insurers. Every insurance company subject to FIO or OFR data requests faces compliance costs for legal review, data extraction, and response preparation. For large multi-line insurers like MetLife and Prudential with substantial federal regulatory exposure (e.g., annual FIO data calls, potential FSOC designation inquiries), these costs can run from tens of millions to over a hundred million dollars annually in legal fees, compliance headcount, and systems. The bill eliminates that federal-level compliance requirement entirely for direct subpoenas. State-based regulation remains intact, so insurers still report to state insurance commissioners per existing state law — the bill shifts the data collection burden back to the states, where regulatory relationships are more established. **Structural Winners and Losers:** The unambiguous winners are all U.S. insurance companies. The largest benefit accrues to life insurers with significant reserves and variable annuity blocks (MET, PRU, LNC) because they are most likely to be targeted by federal systemic risk regulators. Property-casualty insurers (ALL, TRV, CINF) also benefit from reduced regulatory risk. The bill's restriction on OFR's subpoena power over insurance companies is particularly important for P&C writers with large amounts of policy-level data that could be used for systemic risk modeling. The loser in this framework is the Federal Insurance Office itself — its enforcement and data collection capabilities are eliminated, reducing its relevance and institutional capacity. The bill does not eliminate FIO entirely but strips it of its primary investigative tool. State insurance regulators and the National Association of Insurance Commissioners (NAIC) emerge as relative winners because the bill reinforces their primacy as the primary collectors of insurance data. **Real Market Data:** The real market data shows mixed 7-day performance but broadly positive 30-day trends. MET leads the group with a 30-day gain of +13.29% (from ~$70.70 on April 1 to $80.12 on April 30). UNM is up +10.84% over 30 days. LNC gained +6.73%, TRV +4.46%, and ALL +4.11%. The outlier is AIG, which declined -1.25% in the 7-day and -1.4% in the 30-day, trading at $74.21 — near its 52-week low of $71.25. This divergence suggests market participants are selectively pricing in regulatory relief expectations for well-positioned life and P&C writers while AIG faces company-specific headwinds (AIG's core P&C underwriting and legacy runoff operations may not align with the 'pure insurance' profile benefit the market is assigning to MET, ALL, TRV, and LNC). PRU shows a slight 30-day decline of -0.01% but a strong 7-day +3.68% bounce off the $94 low, indicating the market is still assessing its risk/reward. **Timeline:** HR3437 is in early legislative stages — referred to two committees (Financial Services and Agriculture) on May 15, 2025. No hearings or markups have been reported. The companion bill S1544 is in the Senate Banking Committee. The bill has 24 cosponsors, all Republicans. For passage, it would need to clear both committees, pass the House floor (likely with Republican support, requiring moderate Democratic votes for majority), proceed through Senate Banking Committee mark-up, and pass the Senate floor (potentially via reconciliation or bipartisan deal). The current legislative calendar (late April 2026) is compressed with appropriations deadlines and midterm election positioning. Given early-stage status in a session that ends January 2027, near-term passage risk is moderate — but the existence of a Senate companion bill with bipartisan pathway increases the probability of eventual enactment, possibly as a rider to an omnibus or financial services regulatory reform package.